Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Using a RT-PCR technique, complemented by Southern blot analysis, TTF-1 expression was detected in human C cells (two medullary thyroid carcinomas), but not in normal and adenomatous (four adenomas and three hyperplasia) parathyroid, and normal and adenomatous (six adenomas) pituitary tissues.CaSR was expressed in all samples.
|
11500234 |
2001 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We evaluated the expression of TTF-1 in primary thyroid tissues (normal thyroid, papillary carcinoma and undifferentiated carcinoma) and in thyroid carcinoma cell lines using immunohistochemistry and RT-PCR.
|
19506552 |
2009 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The expression of napsin A is common in thyroid tumors and the combined expression of napsin A and TTF-1 in a metastatic thyroid carcinoma is a cause for concern due to chances of misdiagnosis as lung adenocarcinoma.
|
31788765 |
2020 |
Thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Because TTF1-expressing neoplasms are generated from organs and tissues that normally express TTF1, such as the thyroid follicular epithelium and peripheral lung airway epithelium, TTF1 is widely used as a cell lineage-specific and diagnostic marker for thyroid carcinomas and for lung adenocarcinomas with terminal respiratory unit (TRU) differentiation.
|
23358112 |
2013 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
To correlate the differentiation phenotype of two human thyroid cancer cell lines with their expression of various molecular markers, we analyzed the mRNA levels of four thyroid-specific genes, including thyrotropin receptor (TSHR), thyroglobulin (Tg), thyroid transcription factor-1 (TTF-1), and paired-box containing transcription factor-8 (PAX-8) genes.
|
10810302 |
2000 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Thyroid transcription factor-1 (TTF-1) expression is widely considered a specific marker for lung and thyroid carcinomas and plays an important role in angiogenesis in lung cancer.
|
28843751 |
2017 |
Thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The cotransduction of TTF-1 and Pax-8 gene, with resulting NIS-mediated radioiodine accumulation and TPO and Tg-mediated radioiodine organification and intracellular retention, may lead to effective radioiodine therapy of thyroid carcinoma.
|
22498723 |
2012 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
TPO mRNA expression in differentiated thyroid carcinomas did not always correlate with the mRNA expression of thyroglobulin, thyroid stimulating hormone receptor, and thyroid transcription factor 1.
|
8691351 |
1996 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.
|
10746684 |
2000 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Thyroid transcription factor-1 (TTF-1) is a marker commonly expressed in lung and thyroid carcinomas.
|
18413286 |
2008 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
For this purpose, cell lines derived from papillary (TPC-1 and BHP 10-3) and anaplastic (ARO) thyroid carcinomas were stably transfected with expression vectors containing TTF-1 or PAX-8 genes.
|
27573549 |
2016 |
Thyroid carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Transcriptional regulation of the potential tumor suppressor ABI3 gene in thyroid carcinomas: interplay between methylation and NKX2-1 availability.
|
27036019 |
2016 |
Thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Cotransduction of AdTTF-1 and AdTGTK permitted 90% cytotoxicity for BHP15-3 and >95% cytotoxicity for FRT, as well as for BHP7-13 and BHP18-21v thyroid cancer cell lines [both/TTF1(-)/TTF-2(-)/Pax-8(+)/TG(-)].
|
11325833 |
2001 |
Thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A variant located on 14q13.3 nearest to thyroid transcription factor-1 (TTF1) predisposes individuals to thyroid cancer, but whether this variant is related to the RET/PTC rearrangement associated with human papillary thyroid carcinomas (PTCs) is unknown.
|
24014739 |
2013 |
Thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We therefore examined the effects of overexpression of TTF-1 and PAX-8 on Tg gene promoter activity in the human thyroid carcinoma cell lines, ARO (anaplastic) and WRO (follicular).
|
9854590 |
1998 |
Thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The objective of this study was to test the hypothesis that TITF1 and TITF2 variants modulate thyroid cancer susceptibility.
|
26206751 |
2015 |
Thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The diagnosis of thyroid carcinoma in pleural fluid can be particularly challenging as thyroid transcription factor -1 (TTF-1) which is a marker for carcinoma of thyroid origin is also positive in lung adenocarcinomas (which are more frequently associated with pleural effusions) and thyroglobulin (TG) can often be negative in poorly differentiated/analplastic thyroid carcinomas.
|
27456348 |
2016 |
Thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We evaluated the best tagging SNPs from our previous PTC study and additionally included SNPs in or near FOXE1 and NKX2-1 genes, known susceptibility loci for thyroid cancer.
|
27207655 |
2016 |